血培养与呼吸道培养:肺炎的两种不同视角
该研究纳入2010年7月至2015年6月美国177家医院出院、主要诊断为肺炎或呼吸衰竭等伴继发肺炎诊断且入院时做过血或呼吸道培养的成人住院病例,比较两种培养阳性者的病原菌、耐药与结局。138 561例中12 888例(9.3%)培养阳性;呼吸道分离株对社区获得性肺炎一线治疗耐药比例高于血分离株(54.2% vs 26.6%,P < .001),两部位均阳性者病死率、住院时长和费用更高。
要点
- 呼吸道培养分离株耐药率高于血培养分离株(54.2% vs 26.6%)。
- 呼吸道培养最常见为金黄色葡萄球菌(34%)和铜绿假单胞菌(17%)。
- 血培养最常见为肺炎链球菌(33%),其次为金黄色葡萄球菌(22%)。
核心结论
- 培养阳性的呼吸道标本患者与血培养阳性患者在临床特征上不同,耐药模式因培养来源而异。
- 抗菌药物耐药预测模型应考虑培养来源。
研究设计与样本
- 多中心回顾性队列研究,纳入美国177家医院2010年7月至2015年6月出院的成人肺炎相关住院患者。
- 共138 561例入院时行血或呼吸道培养的肺炎住院病例,其中12 888例(9.3%)培养阳性。
主要发现
- 12 888例阳性中呼吸道培养6438例、血培养5992例、两者均阳性458例。
- 呼吸道分离株耐药比例高于血分离株(54.2% vs 26.6%;P < .001)。
- 两部位均阳性者较仅血或仅呼吸道阳性者病死率更高、住院时间更长、费用更高。
- 呼吸道培养最常见病原为金黄色葡萄球菌(34%)和铜绿假单胞菌(17%),血培养最常见为肺炎链球菌(33%)后接金黄色葡萄球菌(22%)。
临床怎么用
- 经验性抗感染治疗及耐药风险预测应结合培养来源,不能将血与呼吸道培养结果等同看待。
- 两部位培养均阳性提示病情更重、资源使用更高,需加强评估与处置。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Choice of empiric therapy for pneumonia depends on risk for antimicrobial resistance. Models to predict resistance are derived from blood and respiratory culture results. We compared these results to understand if organisms and resistance patterns differed by site. We also compared characteristics and outcomes of patients with positive cultures by site. METHODS: We studied adult patients discharged from 177 US hospitals from July 2010 through June 2015, with principal diagnoses of pneumonia, or principal diagnoses of respiratory failure, acute respiratory distress syndrome, respiratory arrest, or sepsis with a secondary diagnosis of pneumonia, and who had blood or respiratory cultures performed. Demographics, treatment, microbiologic results, and outcomes were examined. RESULTS: Among 138 561 hospitalizations of patients with pneumonia who had blood or respiratory cultures obtained at admission, 12 888 (9.3%) yielded positive cultures: 6438 respiratory cultures, 5992 blood cultures, and 458 both respiratory and blood cultures. Forty-two percent had isolates resistant to first-line therapy for community-acquired pneumonia. Isolates from respiratory samples were more often resistant than were isolates from blood (54.2% vs 26.6%; P < .001). Patients with both culture sites positive had higher case-fatality, longer lengths of stay, and higher costs than patients who had only blood or respiratory cultures positive. Among respiratory cultures, the most common pathogens were Staphylococcus aureus (34%) and Pseudomonas aeruginosa (17%), whereas blood cultures most commonly grew Streptococcus pneumoniae (33%), followed by S. aureus (22%). CONCLUSIONS: Patients with positive respiratory tract cultures are clinically different from those with positive blood cultures, and resistance patterns differ by source. Models of antibiotic resistance should account for culture source.
引用
- Haessler S, Lindenauer PK, Zilberberg MD, et al. Blood Cultures Versus Respiratory Cultures: 2 Different Views of Pneumonia. Clin Infect Dis. 2020. PMID: 31665249. doi:10.1093/cid/ciz1049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。